- Home
- ALT vs LYTS Comparison
ALT vs LYTS Comparison
Compare ALT & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | LYTS |
|---|---|---|
| Founded | 1997 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Products |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 703.3M |
| IPO Year | 2005 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ALT | LYTS |
|---|---|---|
| Price | $3.57 | $19.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $17.67 | ★ $27.50 |
| AVG Volume (30 Days) | ★ 2.8M | 271.4K |
| Earning Date | 01-01-0001 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | ★ 25.37 | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | $41,000.00 | ★ $573,377,000.00 |
| Revenue This Year | N/A | $8.01 |
| Revenue Next Year | $756,308.50 | $7.03 |
| P/E Ratio | ★ N/A | $44.73 |
| Revenue Growth | ★ 105.00 | 22.09 |
| 52 Week Low | $2.91 | $13.77 |
| 52 Week High | $7.73 | $24.75 |
Technical Indicators
Market Signals| Indicator | ALT | LYTS |
|---|---|---|
| Relative Strength Index (RSI) | 35.94 | 33.78 |
| Support Level | $3.40 | $18.79 |
| Resistance Level | $4.25 | $19.41 |
| Average True Range (ATR) | 0.23 | 0.77 |
| MACD | -0.04 | -0.20 |
| Stochastic Oscillator | 12.77 | 14.49 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About LYTS LSI Industries Inc.
LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Display solutions segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets, including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells, and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.